Saying it its responding to a growing need of life science firms to offer advice and support across their product lines, INC Research is expanding to offer a new business unit known as Strategic Advisory Services.

“We’re excited to offer strategic advisory capabilities to biopharmaceutical companies in a more integrated way,” said Tim Dietlin, an INC executive who will lead the new group and is senior vice president for Global Consulting and Strategic Alliances.

“Working as an integrated team gives our expert advisors better visibility into our customers’ product development lifecycles and needs, enabling a true strategic partnership to evolve,” he added. “This model allows greater flexibility and agility to identify opportunities, anticipate challenges and offer a broader range of perspectives and options for how to best address them.”

INC focuses on clinical research organization, or CRO, services, and helps clients develop as well as commercialize products.

The new group will focus on:

  • Stragtegic management consulting through its AVOS Consulting division
  • Regulatory consulting and submissions
  • Compliance consulting